Landscape Capital Management L.L.C. Sells 24,021 Shares of The Clorox Company (NYSE:CLX)

Landscape Capital Management L.L.C. lowered its holdings in The Clorox Company (NYSE:CLX - Free Report) by 42.6% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 32,397 shares of the company's stock after selling 24,021 shares during the quarter. Clorox makes up 0.5% of Landscape Capital Management L.L.C.'s portfolio, making the stock its 28th biggest position. Landscape Capital Management L.L.C.'s holdings in Clorox were worth $5,278,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of the stock. Mizuho Securities USA LLC grew its position in shares of Clorox by 46,877.8% in the 3rd quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company's stock worth $733,095,000 after buying an additional 4,490,421 shares during the last quarter. Nuance Investments LLC increased its stake in shares of Clorox by 150.6% in the second quarter. Nuance Investments LLC now owns 1,597,674 shares of the company's stock worth $218,035,000 after acquiring an additional 960,094 shares during the period. Van ECK Associates Corp lifted its holdings in shares of Clorox by 2.2% in the 3rd quarter. Van ECK Associates Corp now owns 1,492,717 shares of the company's stock valued at $237,372,000 after buying an additional 31,510 shares during the period. Bank of New York Mellon Corp boosted its position in Clorox by 14.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 961,387 shares of the company's stock worth $131,200,000 after purchasing an additional 120,716 shares in the last quarter. Finally, Dimensional Fund Advisors LP grew its position in Clorox by 11.9% during the second quarter. Dimensional Fund Advisors LP now owns 802,237 shares of the company's stock valued at $109,483,000 after buying an additional 85,529 shares during the period. Hedge funds and other institutional investors own 78.53% of the company's stock.

Clorox Stock Down 0.1 %

Shares of NYSE:CLX opened at $168.05 on Thursday. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62. The stock has a market cap of $20.80 billion, a P/E ratio of 58.55, a P/E/G ratio of 3.11 and a beta of 0.41. The Clorox Company has a 1-year low of $127.60 and a 1-year high of $169.21. The firm has a fifty day moving average price of $162.64 and a 200 day moving average price of $148.08.

Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, topping the consensus estimate of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The business had revenue of $1.76 billion during the quarter, compared to analysts' expectations of $1.64 billion. During the same quarter in the prior year, the business earned $0.49 earnings per share. The company's quarterly revenue was up 27.0% compared to the same quarter last year. Sell-side analysts predict that The Clorox Company will post 6.85 EPS for the current year.

Clorox Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be given a $1.22 dividend. This represents a $4.88 annualized dividend and a yield of 2.90%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox's payout ratio is 170.04%.

Analyst Ratings Changes

Several brokerages have recently issued reports on CLX. BNP Paribas upgraded shares of Clorox to a "strong sell" rating in a research report on Friday, September 6th. DA Davidson raised their target price on Clorox from $153.00 to $171.00 and gave the stock a "neutral" rating in a research note on Monday, November 4th. Deutsche Bank Aktiengesellschaft upped their price target on Clorox from $144.00 to $151.00 and gave the stock a "hold" rating in a research note on Friday, August 2nd. Jefferies Financial Group raised shares of Clorox from a "hold" rating to a "buy" rating and raised their price objective for the company from $174.00 to $187.00 in a research note on Tuesday, October 1st. Finally, Citigroup boosted their target price on Clorox from $165.00 to $170.00 and gave the stock a "neutral" rating in a research note on Friday, September 6th. Five research analysts have rated the stock with a sell rating, ten have issued a hold rating and one has issued a buy rating to the company. According to MarketBeat, the stock has an average rating of "Hold" and an average price target of $155.00.

Insider Activity

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of Clorox stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the transaction, the executive vice president now owns 13,471 shares in the company, valued at approximately $2,229,719.92. The trade was a 11.40 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 0.57% of the company's stock.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.